Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
biotech
boston blog main
boston top stories
fda
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
abbvie
acorda therapeutics
aimmune therapeutics
allergy
amgen
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
daniel edelman
detroit blog main
detroit top stories
drugs
duopa
eli lilly
eosinophilic esophagitis
episodic migraine
food allergy
immunotherapy
inbrija
indiana
jayson dallas
What
approved
3
×
drug
3
×
fda
late
3
×
approval
developed
friday
new
won
acorda
agency
aimmune
allergy
announced
awarded
class
cope
decision
disease
eli
episodes
gets
headache
help
immunotherapy
lilly
looms
marks
meant
medications
medicines
migraine
nod
oral
pain
parkinson’s
patients
peanut
prevent
rival
Language
unset
Current search:
late
×
approved
×
drug
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines